Metastate has released a public technical whitepaper introducing Peptide-Lab, a modular, AI-assisted discovery pipeline designed to identify short, food-like peptides with potential to stimulate GLP-1 secretion from gut L-cells.
Peptide-Lab integrates virtual protein digestion, explainable multi-factor scoring, peptide 3D structure prediction, docking-based prioritization, and a closed experimental feedback loop. The pipeline is explicitly designed to reduce experimental noise by filtering low-probability candidates before wet-lab validation.
Can peptides be patented? In general, patentability depends on the specific peptide compositions, novelty, non-obviousness, utility, and the claims around the discovery or application framework. Metastate's provisional filing covers both peptide compositions and the associated discovery framework described in the whitepaper.
The published document is intentionally non-confidential and excludes proprietary sequences and assay data. Computational outputs are framed as prioritization signals rather than biological proof, with validation partners needed for GLP-1 secretion assays, receptor pharmacology readouts, and peptide stability panels.